Dermatology

Latest News

Povorcitinib Shows Hope for Patients with Hidradenitis Suppurativa in Phase 3 Trials
Povorcitinib Shows Hope for Patients with Hidradenitis Suppurativa in Phase 3 Trials

September 17th 2025

Povorcitinib shows promising results for hidradenitis suppurativa, offering significant lesion reduction and pain relief in recent phase 3 trials.

Research Shows Hidradenitis Suppurativa Impacts 1% Globally, With Women More Affected
Research Shows Hidradenitis Suppurativa Impacts 1% Globally, With Women More Affected

September 15th 2025

New Data at EADV Could Offer Hope, Address Gaps in Dermatology Care
New Data at EADV Could Offer Hope, Address Gaps in Dermatology Care

September 11th 2025

GLP-1 Medications Show Promise in Treating Hidradenitis Suppurativa
GLP-1 Medications Show Promise in Treating Hidradenitis Suppurativa

August 19th 2025

Dupixent Shows Promise for Treating Atopic Dermatitis with Alopecia and Vitiligo
Dupixent Shows Promise for Treating Atopic Dermatitis with Alopecia and Vitiligo

August 14th 2025

Latest CME Events & Activities

More News

© 2025 MJH Life Sciences

All rights reserved.